POINT Biopharma Global In...

NASDAQ: PNT · Real-Time Price · USD
12.50
0.02 (0.16%)
At close: Dec 26, 2023, 10:00 PM

POINT Biopharma Global Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
286.43M 238.82M
Short-Term Investments
238.78M n/a
Long-Term Investments
16.12M n/a
Other Long-Term Assets
-47.5M -19.41M
Receivables
60.22K 72.67K
Inventory
5.34M 4.85M
Other Current Assets
215.2K 105.45K
Total Current Assets
530.82M 243.85M
Property-Plant & Equipment
31.38M 19.41M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
47.5M 19.41M
Total Assets
578.32M 263.26M
Account Payables
7.68M 1.74M
Deferred Revenue
23.24M n/a
Short-Term Debt
n/a n/a
Other Current Liabilities
48.82M 6.24M
Total Current Liabilities
79.74M 7.98M
Long-Term Debt
n/a n/a
Other Long-Term Liabilities
1.45M n/a
Total Long-Term Liabilities
11.63M 65.59K
Total Liabilities
91.37M 8.05M
Total Debt
n/a n/a
Common Stock
10.56K 9.01K
Retained Earnings
39.01M -59.28M
Comprehensive Income
-456.85K n/a
Shareholders Equity
486.95M 255.21M
Total Investments
238.78M n/a